埃索美拉唑治疗老年脑卒中合并胃食管反流病患者的疗效与安全性评价
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

四川省卫计委干保课题


Clinical effects and safety of esomeprazole in the treatment of stroke complicating gastroesophageal reflux disease in aged people
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨与评价埃索美拉唑对老年脑卒中患者合并胃食管反流病的疗效和安全性。方法 纳入64例合并胃食管反流病的脑卒中老年患者,随机分为为研究组和对照组,每组各32例。研究组予以埃索美拉唑口服,1次/d,40mg/次;对照组予以奥美拉唑口服1次/d,20mg/次,均治疗8周后比较两组患者治疗前后临床疗效、内镜下评分及不良反应。结果 两组患者胸痛、反酸、烧灼感等症状经治疗后均改善明显,研究组总有效率与对照组比较,差异有统计学意义(P<005)。两组患者的药物不良反应发生率比较差异无统计学意义(P>005)。 结论 埃索美拉唑为治疗合并胃食管反流病的脑卒中老年患者安全、有效的药物,可在临床推广应用。

    Abstract:

    【Abstract】 Objective To examine the clinical efficacy and security of esomeprazole in therapy of stroke complicating gastroesophageal reflux disease in the aged people. Methods Sixtyfour patients were randomly divided into treatment group (32 cases) and control group (32 cases). The patients in treatment group were orally administrated with esomeprazole 40 mg once a day. The people in the matched group were administrated with Omeprazole 20mg once a day. Clinical efficacy and the drug adverse reaction were compared between the two groups after treatment for 8 weeks.Results The symptoms of chest pain,acid reflux and heartburn in two groups were improved after treatment for 8 weeks. The efficient in treatment group (8438%) was higher than that in control group (7188%), (P<0.05).The incidences of adverse reaction of treatment group and control group were 94% and 63% ( P> 0. 05). Conclusion Esomeprazole is effective and safe in the treatment of stroke complicating gastroesophageal reflux disease in the aged people.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-06-28
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司